Company page

Biodesix, Inc.

Biodesix, Inc. (ticker: BDSX) is a public company operating in the American market, with a market capitalization of approximately $227.8 million. The company focuses on developing diagnostic solutions for patients with lung diseases. Biodesix aims to improve patient outcomes through innovative testing and personalized medicine approaches.